CEL-SCI Corp.

Not Rated
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US1508376076
USD
3.48
0.04 (1.16%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
CEL-SCI Corp. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Sep'25
Sep'24
Sep'23
Sep'22
Sep'21
Sep'20
No of Months
12
12
12
12
12
12
Profit Before Tax
-25.00
-26.00
-32.00
-36.00
-36.00
-30.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
1.00
-1.00
0.00
0.00
0.00
-1.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-17.00
-18.00
-20.00
-20.00
-18.00
-15.00
Cash Flow from Investing Activities
0.00
0.00
0.00
5.00
-15.00
-2.00
Cash Flow from Financing Activities
23.00
19.00
4.00
0.00
54.00
25.00
Net Cash Inflow / Outflow
6.00
0.00
-16.00
-15.00
20.00
7.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in USD Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of CEL-SCI Corp.
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Profit Before Tax
-25.411055
-16.268
-9.00
-56.20%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
1.162415
-2.101
3.00
155.33%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-17.116152
-15.22
-2.00
-12.46%
Cash Flow from Investing Activities
-0.038109
6.354
-6.00
-100.60%
Cash Flow from Financing Activities
23.373133
2.9
21.00
705.97%
Net Cash Inflow / Outflow
6.218872
-5.966
11.00
204.24%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Sep'25
stock-summary

YoY Growth in year ended Sep 2025 is 9.01% vs 8.35% in Sep 2024

Sep'25
Sep'24
Change(%)
Cash Flow from Operating Activities
-17.12
-18.81
9.01%